1-3 of 3
Ayed O Ayed, MD
Close
Sort by
Journal Articles

Lenalidomide Plus R-CHOP (R2CHOP) in Patients with Follicular Lymphoma: Data from a Phase 1/2 Study

Ayed O. Ayed, MD, Levi Pederson, William R. Macon, MD, Betsy R. Laplant, MS, Craig B. Reeder, MD, James M. Foran, MD, Garth Nelson, Candido E. Rivera, MD, Thomas M. Habermann, MD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD
Journal: Blood
Blood (2016) 128 (22): 5322.
https://doi.org/10.1182/blood.V128.22.5322.5322
Published: 2016
Journal Articles

Lenalidomide Plus R-CHOP (R2CHOP) in Patients with DLBCL Is Associated with a Lower Risk of CNS Relapse: Combined Analysis from Two Phase 2 Studies

Ayed O. Ayed, MD, Annalisa Chiappella, MD, Grzegorz S. Nowakowski, MD, Federica Cavallo, MD, Angela Giovanna Congiu, MD, Gianluca Gaidano, MD PhD, Levi Pederson, Betsy R. Laplant, MS, William R. Macon, MD, Gerardo Musuraca, MD, Alessandro Re, MD, Michele Spina, Thomas E. Witzig, MD, Umberto Vitolo
Journal: Blood
Blood (2016) 128 (22): 3033.
https://doi.org/10.1182/blood.V128.22.3033.3033
Published: 2016
Journal Articles

Severe Diffuse Alveolar Hemorrhage Associated with Bortezomib Administration in Patients with Multiple Myeloma

Ayed O Ayed, MD, Jan S Moreb, MD, Jack W. Hsu, MD, John W Hiemenz, MD, John R Wingard, MD, Maxim Norkin, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5761.
https://doi.org/10.1182/blood.V124.21.5761.5761
Published: 2014